Send feedback

ATL1 p.Arg446His

c.1337G>A · rs760599236 · VCV1914078

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.9546 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000763%, nfe)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
hereditary spastic paraplegia 3A

Computational evidence

Protein change
AlphaMissense0.9546likely pathogenic
REVEL0.584indeterminate
SaProtLLR -12.84damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 1.8, phastCons 1
Regional constrainto/e 0.67unconstrained · MANE · 9,131 bp · p 2.1e-07 · regional, not allelic
Overall
CADD32.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000763% European (non-Finnish) · 9/1,180,006 alleles
Filtering AF 0.000359% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00026%
Overall 0.000821% 12/1,461,882 alleles · very rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.00469% 21,341
European (non-Finnish)grpmax 0.000763% 131,112

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
ATL1
Protein
p.Arg446His
Coding
c.1337G>A
MANE Select
NM_015915
dbSNP
rs760599236
Type
single nucleotide variant
Location
chr14:50628248 (GRCh38)
Gene constraint
LOEUF 0.57 · pLI 0.36 · ClinGen HI 0/3 (gnomAD)
Structure
AlphaFold pLDDT 86.49 · 14 PDB
Residue 446
the 'linker' region; an α-helix
Full ATL1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary spastic paraplegia 3A — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Autosomal dominant spastic paraplegia type 3 (Orphanet):

Inheritance
Autosomal dominant
Onset
Adult, Childhood
Prevalence
1-9 / 1 000 000 (Portugal)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/atl1-p-arg446his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown